106 related articles for article (PubMed ID: 9213331)
21. Evaluation of AgNORs in pulmonary lesions: a cyto-histopathological correlation.
Gulati A; Sharma J; Sharma BB; Kaushik R; Kashyap S
Indian J Pathol Microbiol; 2002 Jul; 45(3):289-92. PubMed ID: 12785168
[TBL] [Abstract][Full Text] [Related]
22. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
23. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
Blonski W; Kundu R; Lewis J; Aberra F; Osterman M; Lichtenstein GR
Scand J Gastroenterol; 2008; 43(6):698-703. PubMed ID: 18569987
[TBL] [Abstract][Full Text] [Related]
24. Silver-binding nucleolar organizer regions (AgNORs) in tumors of colon.
Zaczek M; Dabroś E; Szot W; Chłap Z
Pol J Pathol; 1996; 47(4):195-200. PubMed ID: 9097712
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal carcinoma-associated antigen detected by a monoclonal antibody in dysplasia and adenocarcinoma associated with chronic ulcerative colitis.
Olding LB; Ahren C; Thurin J; Karlsson KA; Svalander C; Koprowski H
Int J Cancer; 1985 Aug; 36(2):131-6. PubMed ID: 4018908
[TBL] [Abstract][Full Text] [Related]
27. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
[TBL] [Abstract][Full Text] [Related]
28. Large bowel mucosal dysplasia and carcinoma in ulcerative colitis.
Allen DC; Biggart JD; Pyper PC
J Clin Pathol; 1985 Jan; 38(1):30-43. PubMed ID: 3968207
[TBL] [Abstract][Full Text] [Related]
29. p53 mutation in patients with ulcerative colitis in rectal biopsy.
Kim HJ; Chang SK
Korean J Intern Med; 1998 Jul; 13(2):110-6. PubMed ID: 9735666
[TBL] [Abstract][Full Text] [Related]
30. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
31. Scanning electron microscopic appearance of chronic ulcerative colitis with and without dysplasia.
Shields HM; Bates ML; Goldman H; Zuckerman GR; Mills BA; Best CJ; Bair FA; Goran DA; DeSchryver-Kecskemeti K
Gastroenterology; 1985 Jul; 89(1):62-72. PubMed ID: 4007414
[TBL] [Abstract][Full Text] [Related]
32. Silver-binding argyrophilic nucleolar organizer regions (AgNOR) in gall-bladder cancer: correlations with malignant grading and prognosis.
Suzuki T; Takano Y; Kida Y; Okudaira M
Acta Pathol Jpn; 1993; 43(1-2):36-43. PubMed ID: 8465655
[TBL] [Abstract][Full Text] [Related]
33. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?
Gorfine SR; Bauer JJ; Harris MT; Kreel I
Dis Colon Rectum; 2000 Nov; 43(11):1575-81. PubMed ID: 11089596
[TBL] [Abstract][Full Text] [Related]
34. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
35. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free.
Chen R; Rabinovitch PS; Crispin DA; Emond MJ; Koprowicz KM; Bronner MP; Brentnall TA
Am J Pathol; 2003 Feb; 162(2):665-72. PubMed ID: 12547724
[TBL] [Abstract][Full Text] [Related]
36. Morphometric analysis of AgNORs in thin-layer, liquid-based liver specimens.
Politi EN; Lazaris AC; Alexopoulou D; Lambropoulou S; Kavantzas N; Koutselini H
Anal Quant Cytol Histol; 2004 Aug; 26(4):187-93. PubMed ID: 15457670
[TBL] [Abstract][Full Text] [Related]
37. Nucleolar organizer regions in jaw tumours of cartilaginous origin.
Afolabi OC; Odukoya O; Arole G; Banjo AF
West Afr J Med; 2001; 20(1):17-21. PubMed ID: 11505882
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis.
Thor A; Itzkowitz SH; Schlom J; Kim YS; Hanauer S
Int J Cancer; 1989 May; 43(5):810-5. PubMed ID: 2654025
[TBL] [Abstract][Full Text] [Related]
39. Melanin bleaching in argyrophilic staining of AgNORs in pigmented lesions: a morphometric evaluation.
Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Jun; 24(3):166-72. PubMed ID: 12102129
[TBL] [Abstract][Full Text] [Related]
40. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis.
Orrea SC; Tomasi VH; Schwint AE; Itoiz ME
Biotech Histochem; 2001 Mar; 76(2):67-73. PubMed ID: 11440307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
